Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes?

(MedPage Today) -- Insulins, SGLT2 inhibitors, and GLP-1 receptor agonists can likely be manufactured for prices "far below" their current prices, according to an economic evaluation of manufacturing costs in JAMA Network Open. In related news...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news